Soya products and serum lipids: a meta-analysis of randomised controlled trials
- 13 August 2015
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 114 (6), 831-843
- https://doi.org/10.1017/s0007114515002603
Abstract
Soya proteins and isoflavones have been reported to exert beneficial effects on the serum lipid profile. More recently, this claim is being challenged. The objective of this study was to comprehensively examine the effects of soya consumption on the lipid profile using published trials. A detailed literature search was conducted via MEDLINE (from 2004 through February 2014), CENTRAL (The Cochrane Controlled Clinical Trials Register) andClinicalTrials.govfor randomised controlled trials assessing the effects of soya on the lipid profile. The primary effect measure was the difference in means of the final measurements between the intervention and control groups. In all, thirty-five studies (fifty comparisons) were included in our analyses. Treatment duration ranged from 4 weeks to 1 year. Intake of soya products resulted in a significant reduction in serum LDL-cholesterol concentration, –4·83 (95 % CI –7·34, –2·31) mg/dl, TAG, –4·92 (95 % CI –7·79, –2·04) mg/dl, and total cholesterol (TC) concentrations, –5·33 (95 % CI –8·35, –2·30) mg/dl. There was also a significant increase in serum HDL-cholesterol concentration, 1·40 (95 % CI 0·58, 2·23) mg/dl. TheI2statistic ranged from 92 to 99 %, indicating significant heterogeneity. LDL reductions were more marked in hypercholesterolaemic patients, –7·47 (95 % CI –11·79, –3·16) mg/dl, than in healthy subjects, –2·96 (95 % CI –5·28, –0·65) mg/dl. LDL reduction was stronger when whole soya products (soya milk, soyabeans and nuts) were used as the test regimen, –11·06 (95 % CI –15·74, –6·37) mg/dl, as opposed to when ‘processed’ soya extracts, –3·17 (95 % CI –5·75, –0·58) mg/dl, were used. These data are consistent with the beneficial effects of soya proteins on serum LDL, HDL, TAG and TC concentrations. The effect was stronger in hypercholesterolaemic subjects. Whole soya foods appeared to be more beneficial than soya supplementation, whereas isoflavone supplementation had no effects on the lipid profile.Keywords
This publication has 54 references indexed in Scilit:
- Low and moderate-fat plant sterol fortified soymilk in modulation of plasma lipids and cholesterol kinetics in subjects with normal to high cholesterol concentrations: report on two randomized crossover studiesLipids in Health and Disease, 2009
- Cholesterol lowering effect of a soy drink enriched with plant sterols in a French population with moderate hypercholesterolemiaLipids in Health and Disease, 2008
- The Hypoglycemic Effects of Soy Isoflavones on Postmenopausal WomenJournal of Women's Health, 2004
- Dietary Hydrogenated Fat Increases High-Density Lipoprotein apoA-I Catabolism and Decreases Low-Density Lipoprotein apoB-100 Catabolism in Hypercholesterolemic WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysisEuropean Journal of Clinical Nutrition, 2003
- Beneficial Effects of Soybean Isoflavone Supplementation on Bone Metabolism and Serum Lipids in Postmenopausal Japanese Women: A Four-Week StudyJournal of the American College of Nutrition, 2002
- Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal womenThe American Journal of Clinical Nutrition, 2001
- Intake of Soy Products Is Associated with Better Plasma Lipid Profiles in the Hong Kong Chinese PopulationJournal of Nutrition, 2000
- Ecological study of the association between soy product intake and mortality from cancer and heart disease in JapanInternational Journal of Epidemiology, 2000
- Dietary Intakes of Flavonols, Flavones and Isoflavones by Japanese Women and the Inverse Correlation between Quercetin Intake and Plasma LDL Cholesterol ConcentrationJournal of Nutrition, 2000